Literature DB >> 20458006

Impaired endothelial repair capacity of early endothelial progenitor cells in prehypertension: relation to endothelial dysfunction.

Giovanna Giannotti1, Carola Doerries, Pavani S Mocharla, Maja F Mueller, Ferdinand H Bahlmann, Tibor Horvàth, Hong Jiang, Sajoscha A Sorrentino, Nora Steenken, Costantina Manes, Mario Marzilli, K Lenhard Rudolph, Thomas F Lüscher, Helmut Drexler, Ulf Landmesser.   

Abstract

Prehypertension is a highly frequent condition associated with an increased cardiovascular risk. Endothelial dysfunction is thought to promote the development of hypertension and vascular disease; however, underlying mechanisms remain to be further determined. The present study characterizes for the first time the in vivo endothelial repair capacity of early endothelial progenitor cells (EPCs) in patients with prehypertension/hypertension and examines its relation with endothelial function. Early EPCs were isolated from healthy subjects and newly diagnosed prehypertensive and hypertensive patients (n=52). In vivo endothelial repair capacity of EPCs was examined by transplantation into a nude mouse carotid injury model. EPC senescence was determined (RT-PCR of telomere length). NO and superoxide production of EPCs were measured using electron spin resonance spectroscopy analysis. CD34(+)/KDR(+) mononuclear cells and circulating endothelial microparticles were examined by fluorescence-activated cell sorter analysis. Endothelium-dependent and -independent vasodilations were determined by high-resolution ultrasound. In vivo endothelial repair capacity of EPCs was substantially impaired in prehypertensive/hypertensive patients as compared with healthy subjects (re-endothelialized area: 15+/-3%/13+/-2% versus 28+/-3%; P<0.05 versus healthy subjects). Senescence of EPCs in prehypertension/hypertension was substantially increased, and NO production was markedly reduced. Moreover, reduced endothelial repair capacity of early EPCs was significantly related to an accelerated senescence of early EPCs and impaired endothelial function. The present study demonstrates for the first time that in vivo endothelial repair capacity of early EPCs is reduced in patients with prehypertension and hypertension, is related to EPC senescence and impaired endothelial function, and likely represents an early event in the development of hypertension.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20458006     DOI: 10.1161/HYPERTENSIONAHA.109.141614

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  65 in total

Review 1.  Functional neural-bone marrow pathways: implications in hypertension and cardiovascular disease.

Authors:  Jasenka Zubcevic; Monica M Santisteban; Teresa Pitts; David M Baekey; Pablo D Perez; Donald C Bolser; Marcelo Febo; Mohan K Raizada
Journal:  Hypertension       Date:  2014-03-31       Impact factor: 10.190

2.  The effect of bone marrow mononuclear stem cell therapy on left ventricular function and myocardial perfusion.

Authors:  Kamel Sadat; Sameer Ather; Wael Aljaroudi; Jaekyeong Heo; Ami E Iskandrian; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2013-12-31       Impact factor: 5.952

Review 3.  A reappraisal of the role of circulating (progenitor) cells in the pathobiology of diabetic complications.

Authors:  G P Fadini
Journal:  Diabetologia       Date:  2013-10-31       Impact factor: 10.122

Review 4.  The impact of hypertension on leukocyte telomere length: a systematic review and meta-analysis of human studies.

Authors:  M L Tellechea; C J Pirola
Journal:  J Hum Hypertens       Date:  2016-06-30       Impact factor: 3.012

5.  P.R4810K, a polymorphism of RNF213, the susceptibility gene for moyamoya disease, is associated with blood pressure.

Authors:  Akio Koizumi; Hatasu Kobayashi; Wanyang Liu; Yukiko Fujii; S T M L D Senevirathna; Shanika Nanayakkara; Hiroko Okuda; Toshiaki Hitomi; Kouji H Harada; Katsunobu Takenaka; Takao Watanabe; Shinichiro Shimbo
Journal:  Environ Health Prev Med       Date:  2012-08-10       Impact factor: 3.674

Review 6.  Stem and progenitor cell-based therapy in ischaemic heart disease: promise, uncertainties, and challenges.

Authors:  Jörn Tongers; Douglas W Losordo; Ulf Landmesser
Journal:  Eur Heart J       Date:  2011-02-28       Impact factor: 29.983

7.  Circulating endothelial and progenitor cells: Evidence from acute and long-term exercise effects.

Authors:  Matina Koutroumpi; Stavros Dimopoulos; Katherini Psarra; Theodoros Kyprianou; Serafim Nanas
Journal:  World J Cardiol       Date:  2012-12-26

Review 8.  Prehypertension: Underlying pathology and therapeutic options.

Authors:  Sulayma Albarwani; Sultan Al-Siyabi; Musbah O Tanira
Journal:  World J Cardiol       Date:  2014-08-26

9.  AHA/ACC-defined stage 1 hypertensive adults do not display cutaneous microvascular endothelial dysfunction.

Authors:  Gabrielle A Dillon; Jody L Greaney; Sean Shank; Urs A Leuenberger; Lacy M Alexander
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-07-31       Impact factor: 4.733

10.  Altered inflammatory response is associated with an impaired autonomic input to the bone marrow in the spontaneously hypertensive rat.

Authors:  Jasenka Zubcevic; Joo Yun Jun; Seungbum Kim; Pablo D Perez; Aqeela Afzal; Zhiying Shan; Wencheng Li; Monica M Santisteban; Wei Yuan; Marcelo Febo; Jay Mocco; Yumei Feng; Edward Scott; David M Baekey; Mohan K Raizada
Journal:  Hypertension       Date:  2013-12-23       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.